TGTX
Tg Therapeutics Inc
$34.55
Earnings Summary
Revenue | $83.88Mn |
Net Profits | $3.88Mn |
Net Profit Margins | 4.63% |
Highlights
Tg Therapeutics Inc’s revenue fell -49.41% since last year same period to $83.88Mn in the Q3 2024. On a quarterly growth basis, Tg Therapeutics Inc has generated 14.17% jump in its revenue since last 3-months.
Tg Therapeutics Inc’s net profit fell -96.59% since last year same period to $3.88Mn in the Q3 2024. On a quarterly growth basis, Tg Therapeutics Inc has generated -43.6% fall in its net profits since last 3-months.
Tg Therapeutics Inc’s net profit margin fell -93.27% since last year same period to 4.63% in the Q3 2024. On a quarterly growth basis, Tg Therapeutics Inc has generated -50.6% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Tg Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | 0.03 |
EPS Estimate Current Year | 0.03 |
Highlights
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.03 - a 160% jump from last quarter’s estimates.
Tg Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.03.
Key Ratios
Key ratios of the Tg Therapeutics Inc post its Q3 2024 earnings
Earning Per Share (EPS) | 0.02 |
Highlights
Tg Therapeutics Inc’s earning per share (EPS) fell -97.26% since last year same period to 0.02 in the Q3 2024. This indicates that the Tg Therapeutics Inc has generated -97.26% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-06 | -0.04 | -0.07 | -75% |
2024-11-07 | 0.03 | 0.02 | -33.33% |
2024-08-09 | -0.05 | 0.04 | 180% |
₹0 US Stocks a/c Opening Fee